For research use only. Not for therapeutic Use.
SCD1/5-IN-1 (Cat No.: I040173) is a small-molecule dual inhibitor targeting both Stearoyl-CoA desaturase 1 (SCD1) and SCD5 enzymes, which are involved in the synthesis of monounsaturated fatty acids. These enzymes play critical roles in lipid metabolism and are implicated in various metabolic disorders, including obesity, diabetes, and certain cancers. By inhibiting both SCD1 and SCD5, this compound aims to modulate lipid profiles and disrupt abnormal metabolic processes, offering potential therapeutic applications in managing metabolic diseases and related conditions.
| CAS Number | 1241494-17-6 |
| Synonyms | 5-(furan-2-yl)-N-(1-methylpyrazol-4-yl)-1,2-oxazole-3-carboxamide |
| Molecular Formula | C12H10N4O3 |
| Purity | ≥95% |
| InChI | InChI=1S/C12H10N4O3/c1-16-7-8(6-13-16)14-12(17)9-5-11(19-15-9)10-3-2-4-18-10/h2-7H,1H3,(H,14,17) |
| InChIKey | FCICSKVGJNZDGZ-UHFFFAOYSA-N |
| SMILES | CN1C=C(C=N1)NC(=O)C2=NOC(=C2)C3=CC=CO3 |
| Reference | [1]. Wrona Iwona, et al. Preparation of isoxazoles for treatment of neurological disease. Patent. WO2019209962. |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
